According to recently published Pharmaion report," United States Autoimmune Disorders
Diagnostics Market Opportunities, 2020 " , the autoimmune disorders
diagnostics market in the United States is anticipated to cross $6 billion sales by 2020.
Vijay Jain, Shekhar Annambhotla, Pratibha Shah, Vivek Shanbhag, Suhas Kshirsagar, Suresh Swarnapuri, Rammohan Rao, Jayarajan Kodikannath, Jayagopal Parla and Jay Apte, will present topics such as: overview of autoimmune disorders
, the importance of panchakarma (detoxification) therapies, Crohn's disease, prakriti (mind-body constitution) identification in autoimmune disorders
, rasayana (rejuvenation) therapies, memory impairment disorders, psoriasis, and more.
This association brings together Isis' RNA-targeted technology platform with experience from Janssen in autoimmune disorders
and therapeutic formulation.
Whether genetic variants associated with autoimmune disorders
offer advantages of their own is, as the scientists like to say, a matter for further research.
causing jaw pain lead to larger food boluses and increased dysphagia.
If someone has an autoimmune disorder
, their immune system mistakenly interprets their body's own tissues as foreign.
Katherine Siminovitch and her team identified the exact means by which an alteration in the gene PTPN22 increases risk for RA and other autoimmune disorders
Major Finding: Autoimmune disorders
were present in 17.
A small percentage of people with autoimmune disorders
have defects in SIAE.
The advancement of such research can have "important implications" not only for lymphedema, but also cancer, AIDS, wound healing, and autoimmune disorders
A snapshot of the global therapeutic scenario for Autoimmune Disorders
June 16, 2015 /PRNewswire/ -- Kezar Life Sciences, a company focused on the discovery and development of drugs targeting protein homeostasis for autoimmune disorders
, announced the completion of a Series A financing totaling $23 million.
Rare variations in a single gene can lead to a wide variety of autoimmune disorders
including diabetes, lupus and rheumatoid arthritis, a new study shows.
The gene applies a kind of ``molecular brake'' to stop the immune system from running amok and causing autoimmune disorders
- diseases in which the body turns on itself and attacks normal cells instead of attacking invading organisms.
Down the road, the team will broaden its focus to include other autoimmune disorders
with suspected environmental triggers, including rheumatoid arthritis, lupus, type 1 diabetes mellitus, multiple sclerosis, scleroderma (a thickening of the skin), and autoimmune thyroid disease.